Pharma-Bio Serv reports Q1 revenue of $2.5M, near breakeven net income

Pharma-Bio Serv, Inc.

2025-Q1 EPS reported $0.00 vs consensus $0.02 ▼ miss (-100.0%)

Revenue for quarter ended Jan 31, 2025 was ~$2.5M, up ~$0.1M YoY.
Net income near breakeven, an increase of ~$0.3M compared to same quarter last year.
CEO cites net revenue growth in served markets with projects in Europe, Asia, and Latin America.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.